In an experimental C6 rat glioma model, targeting FRβ-expressing TAMs with an anti-mouse FRβ monoclonal antibody conjugated to Pseudomonas exotoxin A significantly depleted TAMs and reduced tumor growth [17]. This evidence concerns the gene FOLR2 and central nervous system cancer.